HeartBeam wins FDA Total Product Life Cycle Advisory Program pilot acceptance for heart attack assessment technology

HeartBeam says it won FDA Total Product Life Cycle Advisory Program pilot acceptance for its acute myocardial infarction (heart attack) assessment technology, which offers remote cardiac monitoring and three-dimensional heart signal monitoring.

Detected & updated continuously · Source: Nebula